March 8, 2016

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient's own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system. Read more...

VUMC adopting online provider rating system


For many years, patients who came to Vanderbilt University Medical Center (VUMC) for care would receive a survey asking, among other things, about how they rated the experience, including the professionalism and friendliness of the physician or other health care provider. Read more...

The Grant Chase: Shrinking budgets cramp discovery


Researchers across the nation devoted to basic science -- the people who mine the unknown and map out the pathways to new cancer drugs -- have had their quest curtailed. Federal funding for their work plunged and then flatlined over the past decade. Read more...

Bitter Pill: Cracking the adverse drug reaction code


On the evening of June 12, 2015, Donna Emley took two acetaminophen (Tylenol) for a slight muscle ache and went to bed. The next day, she and her husband drove to Kentucky, where they were planning to spend a week at an organic farm. She awoke at 2 a.m. the following day and noticed that her eyes were nearly swollen shut and there were rash-like red spots on her face, chest, neck and torso. Read more...